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Abstract
The characteristics of hypoxanthine transport were examined in opossum kidney (OK) epithelial cells and Xenopus laevis
oocytes. In both cell types hypoxanthine influx was mediated by two distinct transport systems: a high-affinity Na-
dependent system and a Na-independent transporter. Na-dependent hypoxanthine transport in OK cells was saturable
(Km 0.78 þ 0.29 WM) and was inhibited by guanine, uracil, thymine and 5-fluorouracil (Ki values 0.5^7 WM), whereas adenine
had no effect. Substitutions at the 2- and 4-position had a marked effect on the ability of uracil to inhibit Na/hypoxanthine
influx by OK cells revealing that an oxo group at both the 2- and 4-positions of uracil is required for interacting with the
transporter. The properties of Na-dependent hypoxanthine influx in oocytes were similar to those observed in OK cells. In
particular, xanthine and oxypurinol inhibited hypoxanthine influx, a characteristic not observed previously for the Na/
nucleobase carrier in pig LLC-PK1 renal cells. Na-independent hypoxanthine influx in OK cells and oocytes was of a lower
affinity (Km 90^180 WM). Adenine and guanine inhibited Na-independent hypoxanthine flux in OK cells, but had no effect
in oocytes. Injection of LLC-PK1 mRNA into oocytes resulted in a 1.5-fold stimulation of Na/hypoxanthine flux over
water-injected oocytes. These results reveal further heterogeneity in Na/nucleobase cotransporters. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Some animal cells, such as certain brain cells, in-
testinal enterocytes, bone marrow and erythrocytes
are incapable of de novo purine biosynthesis and
utilise nucleobases derived from extracellular sources
[1]. The ¢rst step of the purine salvage pathway is the
translocation of purine nucleobases across the plas-
ma membranes of mammalian cells through speci¢c
transport proteins. These transport processes are also
of considerable interest since cytotoxic nucleobases
may enter cells via the carriers and inhibition of
transport may enhance the activity of some nucleo-
side and nucleobase analogues currently in use in the
chemotherapy of certain neoplastic diseases and viral
infections [1,2].
Although studies of nucleobase transport have
been restricted to a few cell types, there is increasing
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evidence of multiple pathways for the uptake of these
compounds. Many cells, as typi¢ed by human eryth-
rocytes, possess a medium a⁄nity facilitated-di¡u-
sion system for purine bases (Km of 13^180 WM),
but a low a⁄nity for pyrimidine bases (Km of V4
mM) [3,4]. In other mammalian cells, hypoxanthine
in£ux is catalysed via the nitrobenzylthioinosine
(NBMPR)-insensitive nucleoside transporter (ei),
but with a low a⁄nity [5,6], and data from studies
on S49 cells suggest that at high concentrations, nu-
cleobases interact with the NBMPR-sensitive nucleo-
side transporter (es) [7]. Recently, Na-dependent
nucleobase transport has been demonstrated in a
range of tissues and cell lines [8^13]. These systems
have a high a⁄nity for purine and pyrimidine bases
(Km of 1^30 WM). The Na-dependent nucleobase
transporter in the pig renal epithelial cell line,
LLC-PK1 [8], appears to be distinct from that
present in rabbit choroid plexus [10]. In particular,
adenine, cytosine and xanthine were potent inhibitors
of Na-dependent hypoxanthine transport in the
rabbit choroid plexus, but had no e¡ect on Na-
stimulated in£ux in LLC-PK1 cells. In addition, the
stoichiometric coupling ratio between Na and hy-
poxanthine has been estimated to be 1:1 and 2:1 in
LLC-PK1 cells and choroid plexus, respectively
[8,10]. It is not known if these di¡erences are due
to species di¡erences, or tissue di¡erences, or re£ect
the presence of multiple Na-nucleobase transporters
in animal cells. In addition, we know nothing about
the molecular properties of the speci¢c nucleobase
carriers.
Expression cloning in Xenopus oocytes has proved
particularly successful for the identi¢cation of
cDNAs encoding membrane transporters, e.g. Na-
dependent glucose and nucleoside transporters [14^
16]. An important prerequisite of such studies is to
have some knowledge of the endogenous transport
activity of oocytes especially if this activity is rela-
tively large compared to that resulting from the in-
jection of poly(A) RNA. The goals of this study
were to characterise, compare and contrast nucleo-
base transport in OK cells, a renal epithelial cell line
derived from the early proximal tubule of opossum
[17], and Xenopus laevis oocytes, with the properties
of equilibrative and Na-dependent nucleobase
transporters in LLC-PK1 cells. Additional studies
on exploring the structural determinants for the spe-
ci¢city of uracil as a permeant for the OK nucleobase
co-transporter were also conducted. Following these
studies we sought to identify possible selective inhib-
itors of the oocyte hypoxanthine transporters that
would allow the blocking of the endogenous hypo-
xanthine transport activity prior to expression of het-
erologous mRNA in the oocytes. Preliminary reports
of some of these ¢ndings have been published [18,19].
2. Materials and methods
2.1. Cell culture
OK cells were cultured at 37‡C in 5% CO2 humidi-
¢ed air in Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 10% (v/v) heat-inactivated foetal bo-
vine serum and 2 mM glutamine as previously
described [20]. Cells were subcultured for serial pas-
sage and seeded into 24-well plates at a density of
3U105 cells/well for experimental use. Medium was
changed every 2 days and the day before the uptake
assay. Cells were free of mycoplasma as determined
using Hoechst 33258 stain [21].
2.2. Hypoxanthine uptake by OK monolayers
[3H]Hypoxanthine in£ux by con£uent monolayers
that completely covered the culture well surface as
determined from microscopic examination was meas-
ured at 22‡C as described previously using phos-
phate-free bu¡ers [8]. Uptake rates are expressed as
per mg protein, estimated by the method of Lowry et
al. [22].
2.3. Isolation of mRNA
Large-scale isolation of mRNA from cultured cells
was performed according to the manufacturer’s in-
structions using the PolyATract System 1000 pur-
chased from Promega. The mRNA was dissolved in
RNAse-free water (1 mg/ml) and stored at 370‡C
until use. The integrity and purity of the samples
was checked by agarose gel electrophoresis.
2.4. Oocyte preparation
Oocytes were isolated and prepared for injection of
BBAMEM 77518 31-12-98
M. Shayeghi et al. / Biochimica et Biophysica Acta 1416 (1999) 109^118110
mRNA using standard procedures [23]. In brief, ma-
ture X. laevis were anaesthetised by placing on ice.
After isolation of ovarian fragments, follicular cells
were removed by treatment with 2 mg/ml collagenase
(Type I, Sigma-Aldrich) and 1 mg/ml trypsin inhib-
itor (Type III-O, Sigma^Aldrich) in modi¢ed Barths’
solution (MBS; 88 mM NaCl, 1 mM KCl, 0.33 mM
Ca(NO3)2, 0.41 mM CaCl2 0.82 mM MgSO4, 2.4
mM NaHCO3, 2.5 mM sodium pyruvate, 10 mM
HEPES, pH 7.5) for 1 h at 22‡C. After collagenase
treatment, oocytes were thoroughly washed in Ca2-
free MBS and healthy stage V^VI oocytes were se-
lected and allowed to recover overnight in MBS sup-
plemented with 100 Wg/ml gentamycin sulphate, 50
Wg/ml penicillin and 5% (v/v) foetal calf serum at
16‡C. These oocytes (non-injected) were used to as-
sess endogenous nucleobase transport. In other ex-
periments, healthy oocytes were microinjected with
50 nl of mRNA or RNAse-free water using the
Drummond Nanoject. Injected oocytes were main-
tained in MBS at 16‡C with daily changes of medium
prior to use in the transport studies.
2.5. Hypoxanthine uptake by X. laevis oocytes
Non-injected and injected oocytes (10 per assay
point) were washed with three 1-ml aliquots of
Na-free transport bu¡er (100 mM choline chloride,
2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM
HEPES, pH 7.5) followed by a 30-min preincubation
in the bu¡er at 22‡C. Uptake of [3H]hypoxanthine
was initiated by the addition of 0.2 ml transport
bu¡er to oocytes in the presence and absence of
100 mM NaCl. In Na-free transport bu¡er, NaCl
was replaced with choline chloride. After the
appropriate time intervals, oocytes were washed
with six 1.0-ml aliquots of ice-cold Na-free trans-
port bu¡er. Each oocyte was dissolved in 0.5 ml of
10% SDS and 3H was assayed by liquid-scintillation
counting.
2.6. Chemicals
[G-3H]Hypoxanthine (27.0 Ci/mmol) and [U-
14C]sucrose (626 mCi/mmol) were purchased from
Amersham. Foetal bovine serum was purchased
from Life Technologies. All other chemicals were of
analytical grade.
2.7. Data analysis
All transport experiments with cultured cells were
carried out in triplicate with at least three separate
preparations unless otherwise stated. The errors giv-
en presented in the ¢gures and tables are standard
errors of the mean. In least square ¢ts to the data,
points were weighted according to the inverse of their
relative experimental errors and kinetic constants of
transport determined using the computer programme
Enz¢ter (Elsevier Biosoft).
3. Results
3.1. Hypoxanthine uptake by OK monolayers
Fig. 1 shows a time course of hypoxanthine uptake
(1.4 WM) by con£uent OK monolayers. Hypoxan-
thine in£ux was linear for at least 60 s and was
stimulated 2.6-fold when NMG was replaced with
Na in the extracellular medium. A time interval of
20 s was used in subsequent studies to approximate
the initial rates of transport. Hypoxanthine in£ux
rates in the presence of NMG were further reduced
by 80% by the addition of adenine (3 mM) and pa-
paverine (5 mM) and were similar to hypoxanthine
in£ux rates determined in the presence of Na and
2 mM hypoxanthine (Fig. 1). These results demon-
strate the presence of two distinct transporters that
mediate hypoxanthine uptake in OK cells : a Na-
dependent and a Na-independent system. Na-de-
pendent hypoxanthine in£ux is de¢ned as the di¡er-
ence in uptake in the presence of Na and NMG,
and Na-independent hypoxanthine uptake as that
in the presence of NMG minus that in the presence
of NMG plus 3 mM adenine and 5 mM papaverine.
Both components were shown to exhibit saturable
concentration-dependent curves that conformed to
simple Michaelis^Menten kinetics. The mean kinetic
constants from three separate experiments ( þ S.E.)
were 0.78 þ 0.29 and 180 þ 59 WM for the Km and
130 þ 18 and 2840 þ 430 pmol/mg protein per min
for the Vmax for Na-dependent and -independent
hypoxanthine uptake by OK monolayers, respec-
tively.
The cation speci¢city of the Na-dependent system
was studied by testing the e¡ect of a variety of
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monovalent cations (140 mM chloride salts) as a re-
placement of Na in the transport medium. The data
presented in Table 1 show that replacement of Na
with Li, NH4 , or K
 resulted in at least a 2.3-fold
reduction in the rate of hypoxanthine uptake and
was similar to that in the presence of NMG. These
results demonstrate the signi¢cant Na speci¢city of
hypoxanthine uptake by OK cell monolayers.
The relationship between extracellular sodium con-
centrations (0^140 mM) and Na-dependent hypo-
xanthine uptake was examined. The Na activation
of the initial rate of 1 WM hypoxanthine in£ux re-
vealed a hyperbolic stimulation suggestion a
Na :hypoxanthine stoichiometry of 1:1 (Fig. 2).
Non-linear regression analysis of the data using the
Hill equation [24] resulted in a mean ( þ S.E.) KNa
value of 26 þ 3.9 mM and a Hill coe⁄cient of
1.3 þ 0.3 from three separate experiments.
The potential substrate speci¢city of Na-depend-
ent and -independent hypoxanthine transport sys-
tems in OK cells was examined by testing a wide
range of compounds for their ability to inhibit the
initial rate of 1 WM hypoxanthine uptake (Table 2,
Fig. 3). Of the natural nucleobases tested, thymine,
uracil and guanine were potent inhibitors (apparent
Ki 0.6^5 WM) of Na-dependent hypoxanthine in£ux,
xanthine a moderate inhibitor (apparent KiV35 WM)
and adenine had no e¡ect (Fig. 3 and Table 2). Addi-
tional studies where the concentrations of both thy-
mine and [3H]hypoxanthine were varied, and the
data plotted as 1/v versus I (Dixon plot) revealed
that thymine acted as a competitive inhibitor (appa-
rent Ki value of 4.0 WM). This inhibition pro¢le is
Fig. 2. Extracellular sodium dependence of hypoxanthine up-
take by OK monolayers. OK monolayers were incubated for
20 s at 22‡C with 1 WM [3H]hypoxanthine and varying concen-
trations of extracellular Na (0^140 mM). Osmolarity was
maintained with appropriate concentrations of NMG. Na-de-
pendent hypoxanthine £ux is plotted as a function of extracellu-
lar Na and the data (mean þ S.E. of triplicate values) from
one representative experiment are shown. The least squares ¢t
of the data obtained from three separate experiments
(mean þ S.E.) gave a KNa of 26 þ 3.9 mM with a Hill coe⁄cient
of 1.3 þ 0.3.
Fig. 1. Time course of hypoxanthine uptake in con£uent OK
monolayers. Monolayers were washed with three 1-ml aliquots
of a Na-free medium. Hypoxanthine uptake at 22‡C was initi-
ated by the addition of transport bu¡er (0.2 ml) containing 1.4
WM [3H]hypoxanthine and 140 mM NaCl (a), or 140 mM
NMG (b), or 140 mM NMG plus 3 mM adenine and 5 mM
papaverine (F), or 140 mM NaCl plus 2 mM hypoxanthine
(P). Uptake was terminated by washing the monolayers with
three 1-ml aliquots of ice-cold Na-free medium. Cells were
lysed with 0.5 M NaOH (0.2 ml) and counted for accumulated
radioactivity. Values are the average þ S.E. of triplicate esti-
mates.
Table 1
The e¡ect of cations on hypoxanthine uptake by OK cells
Cation Hypoxanthine in£ux (pmol/mg protein per min)
Na 65.0 þ 1.7
Li 24.5 þ 0.3
K 27.1 þ 0.9
NH4 28.7 þ 0.1
NMG 28.5 þ 0.2
The initial rate of 1 WM [3H]hypoxanthine in£ux (mean þ S.E.
of three independent experiments) was determined in the pres-
ence of a variety of monovalent cations (140 mM chloride
salts).
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Table 2
The e¡ect of a range of compounds and transport inhibitors on hypoxanthine uptake by OK cells
Test compound Na-dependent
apparent Ki (WM)
Ratio Na-independent
apparent Ki (WM)
Uracil 3.9 þ 0.2 1.0 NI
1-Substitution
1-Methyluracil NI ^ NI
2-Substitutions
2-Aminouracil (isocytosine) NI ^ NI
4-Hydroxypyrimidine (2-deoxyuracil) NI ^ NI
2-Thiouracil NI ^ NI
3-Substitutions
3-Methyluracil NI ^ NI
3-Deazuracil s 1000 6 0.004 NI
4-Substitutions
4-Aminouracil (cytosine) NI ^ NI
2-Hydroxypyrimidine (4-deoxyuracil) NI ^ NI
5-Substitutions
5-Chlorouracil 3.9 þ 0.4 1.0 NI
5-Fluorouracil 6.2 þ 0.3 0.63 NI
5-Methyluracil (thymine) 4.2 þ 0.3 0.93 s 1000
5-Nitrouracil s 100 WM 6 0.04 NI
6-Substitutions
6-Methyluracil 24 þ 2.6 0.16 NI
6-Azauracil s 1000 6 0.004
Purine compounds
Guanine 0.6 þ 0.04 6.5 45 þ 2.8
Xanthine 35 þ 4.9 0.11 NI
Adenine s 100 6 0.04 85 þ 22
Oxypurinol 5.2 þ 0.9 0.75 NI
Allopurinol NI ^ NI
Other compounds
Uric acid NI ^ NI
Azidothymidine NI ^ NI
Phloridzin Ni ^ NI
Dipyridamole 0.9 þ 0.08 4.3 s 1000
Dilazep 137 þ 42 0.028 s 1000
Nitrobenzylthioinosine s 100 6 0.04 NI
The initial rate of 1 WM [3H]hypoxanthine in£ux was determined in the presence and absence of Na and varying inhibitor concentra-
tions. The rates of uptake were plotted as a percentage of the control £ux versus log inhibitor concentration (see Fig. 3) and IC50 val-
ues determined. Ki values were calculated from the equation Ki = IC50/(1+L/Km), where L = 1 WM hypoxanthine and the Km values for
Na-dependent and -independent hypoxanthine in£ux were 0.78 and 181 WM, respectively. Ki values are the means þ S.E.M. of at least
three separate experiments. NI, no inhibition (less than 10% of control values) at 100 WM. Ratio = apparent Ki for uracil/apparent Ki
for compound.
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di¡erent to that observed previously with LLC-PK1
cells where xanthine failed to inhibit Na-dependent
hypoxanthine in£ux [8]. Similarly, oxypurinol was
now demonstrated to inhibit Na-dependent hypo-
xanthine in£ux by OK cells (apparent Ki 5.2 þ 0.9
WM), but had no e¡ect on hypoxanthine £ux in
LLC-PK1 cells (Table 3). Interestingly, allopurinol,
the parent compound from which oxypurinol is me-
tabolised, had no e¡ect on either Na-dependent or
-independent hypoxanthine uptake. For the Na-in-
dependent component of hypoxanthine in£ux, of all
the compounds tested, only guanine and adenine ex-
hibited signi¢cant inhibition of the £ux catalysed by
OK cells.
To attempt to provide information on the struc-
ture^activity relationship for the interaction of nucle-
obases with the Na-dependent nucleobase carrier in
OK cells, the e¡ect of uracil analogues as inhibitors
of Na/hypoxanthine uptake were examined. The
apparent Ki values, and the ratio between the appa-
rent Ki value for the reference compound, uracil, and
the apparent Ki value for each compound screened is
shown in Table 2. This ratio indicates the fold in-
crease (values s 1) or decrease (values 6 1) in the
potency of the compound, relative to uracil. The
data clearly demonstrate that substitutions of the 2-
or 4-position oxo group with an amino group (iso-
cytosine, cytosine) or elimination of one of the oxo
groups (2-deoxyuracil, 4-deoxyuracil) severely de-
creased or abolished binding. Similarly, substitution
of the oxo group at the 2-position with thiol failed to
restore binding. Substitution of the hydrogen at ei-
ther the 1- or 3-position of uracil with a hydrophobic
group, such as methyl, also eliminated binding. Re-
placement of the C6 carbon of uracil with a nitrogen
(6-azauracil) also decreased binding that may be re-
lated to the compound being 100% ionised under the
conditions employed [25]. Substitution of the C6 hy-
drogen with a methyl group decreased interaction
with the transporter V6-fold. Replacement of the
5-position hydrogen with groups that are more elec-
tronegative than hydrogen (nitros£uoros chloros
hydrogen) generally inhibited binding to the Na/hy-
poxanthine transporter in OK cells.
3.2. Hypoxanthine uptake by X. laevis oocytes
Preliminary time course experiments of the uptake
of 1 WM hypoxanthine by X. laevis oocytes demon-
strated that uptake was linear for up to 60 min and
was stimulated V5-fold when choline was replaced
with Na in the transport bu¡er. Thus, a time inter-
val of 20 min was chosen in subsequent experiments
to determine initial rates of transport.
The selectivity of the Na requirement for hypo-
xanthine (1 WM) in£ux by oocytes was studied by
replacing Na in the incubation medium with a va-
riety of cations (chloride salts at 100 mM). Results in
Fig. 4. E¡ect of cations on hypoxanthine uptake by Xenopus
laevis oocytes. The initial rate of 1 WM [3H]hypoxanthine in£ux
(mean þ S.E. (n = 10)) was determined in the presence of a varie-
ty of monovalent cations (100 mM chloride salts). Uptake was
also determined in the presence of sodium bu¡er containing
2 mM hypoxanthine (Hyp).
Fig. 3. E¡ect of adenine, 6-methyluracil and 5-chlorouracil on
Na-dependent hypoxanthine uptake in OK monolayers. The
Na-dependent component of 1 WM [3H]hypoxanthine in£ux
was determined in the presence of adenine (S), 6-methyluracil
(E) and 5-chlorouracil (F). The results are from a single experi-
ment performed in triplicate (mean þ S.E.). See Table 2 for
mean Ki values.
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Fig. 4 show that when Na was replaced by choline,
Li, K, Rb or Cs, hypoxanthine uptake was re-
duced by up to 4-fold. These results demonstrate the
high Na speci¢city of hypoxanthine uptake by
Xenopus oocytes, and in further studies Na-depend-
ent hypoxanthine transport was de¢ned as the up-
take in the presence of Na minus that in the pres-
ence of choline. Fig. 4 also revealed the presence of a
second mediated hypoxanthine transport system in
Xenopus oocytes by the observation that addition
of 2 mM hypoxanthine to the Na transport bu¡er
reduced 1 WM [3H]hypoxanthine in£ux to levels be-
low that observed in Na-free bu¡er.
Fig. 5 shows the concentration dependence of
Na-dependent and -independent hypoxanthine in-
£ux by Xenopus oocytes. Hypoxanthine in£ux by
both components was saturable and conformed to
simple Michaelis^Menten kinetics for a single satu-
rable process. The mean ( þ S.E.) kinetic constants
from three separate experiments were 5.8 þ 1.0 and
87 þ 23 WM for the apparent Km with Vmax values
of 7.5 þ 0.5 and 7.3 þ 0.9 pmol/oocyte per h for
Na-dependent and -independent hypoxanthine in-
£ux.
The inhibition pro¢le of the Na-dependent hypo-
xanthine transport component in OK cells showed
distinct di¡erences from that observed for LLC-
PK1 cells. Thus, we tested the e¡ects of a variety
of nucleobases on both Na-dependent and -inde-
pendent hypoxanthine in£ux by Xenopus oocytes.
Table 3 shows that xanthine and oxypurinol, nucle-
obases that inhibited Na-dependent hypoxanthine
in£ux in OK cells, but not LLC-PK1 cells, also in-
hibited Na/hypoxanthine cotransport in oocytes.
The kinetics of uracil inhibition of Na-dependent
hypoxanthine uptake were further analysed. Fig. 6
shows the results of an experiment where the e¡ect
of varying the concentration of uracil on Na-de-
pendent hypoxanthine £ux by oocytes at di¡ering
concentrations of the permanent is plotted as 1/v
Fig. 6. Dixon plot of uracil inhibition of Na-dependent hypo-
xanthine uptake by Xenopus laevis oocytes. The reciprocals of
the rate of Na-dependent hypoxanthine uptake (mean þ S.E.
of triplicate values) (1 WM (b), 6 WM (E) and 10 WM (8)) are
plotted against graded concentrations of uracil. Apparent Ki
value V2.5 WM.
Fig. 5. Concentration dependence of hypoxanthine uptake in
Xenopus laevis oocytes. Oocytes were incubated with varying
concentrations of [3H]hypoxanthine in transport bu¡ers con-
taining either Na, or choline, or choline plus 2 mM hypoxan-
thine. The Na-dependent and -independent £ux components of
hypoxanthine uptake were determined and plotted with the ki-
netic constants shown on the ¢gures. The mean ( þ S.E.) Km
and Vmax values for Na-dependent and -independent hypoxan-
thine £ux from three separate experiments were 5.8 þ 1.0 and
87 þ 23 WM and 7.5 þ 0.5 and 7.3 þ 0.9 pmol/oocyte per h, re-
spectively.
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versus I (Dixon plot). The plot was consistent with
competitive inhibition and gave an apparent Ki value
of 2.5 WM. None of the compounds listed in Table 3
inhibited Na-independent hypoxanthine in£ux by
oocytes at 100 WM.
3.3. Expression of heterologous Na+/hypoxanthine
transporters in oocytes
The di¡erent inhibition pro¢les of Na-dependent
hypoxanthine in£ux by Xenopus oocytes and LLC-
PK1 cells raised the possibility that the endogenous
Na-dependent component of hypoxanthine uptake
could be selectively blocked by addition of xanthine.
Table 4 shows the results of this approach and the
subsequent expression of Na-dependent hypoxan-
thine uptake following injection of LLC-PK1 poly-
(A) RNA. Total Na-dependent hypoxanthine up-
take was stimulated 1.5-fold in oocytes microinjected
with LLC-PK1 mRNA compared to water-injected
oocytes. Addition of 100 WM xanthine reduced
Na-dependent hypoxanthine transport in both con-
trol water-injected oocytes and mRNA-injected oo-
cytes, but a signi¢cant di¡erence between the two
samples was still apparent. Unfortunately, subse-
quent experiments with di¡erent batches of both oo-
cytes and mRNA revealed that the expression of
Na-dependent hypoxanthine transport was variable.
4. Discussion
The present investigation extends a previous study
[8] demonstrating the presence of Na-dependent
and -independent hypoxanthine transport in renal
derived cultured cells. In addition, the structure^ac-
tivity relationship of the permeant site of the Na/
hypoxanthine transporter has been explored and pre-
liminary attempts to functionally express a renal nu-
cleobase transporter in X. laevis oocytes are pre-
sented.
The cultured renal epithelial cell line established
from early proximal tubules of the opossum (desig-
nated OK) kidney [17] was shown to possess Na-
dependent hypoxanthine transport activity. The
transporter had a similar high-a⁄nity (Km of
0.78 þ 0.29 WM) to that determined for the Na-de-
pendent nucleobase transporter in pig LLC-PK1 late
proximal tubule cells (Km 0.79 þ 0.43 WM) [8]. The
Na :hypoxanthine coupling stoichiometry in both
cell types was estimated to be 1:1, but the Vmax
was approximately 9-fold higher for the Na/hypo-
xanthine cotransporter in OK cells (Vmax of 132 þ 18
versus 15 þ 4 pmol/mg protein per min). The higher
Vmax may be of physiological signi¢cance in ensuring
e⁄cient reabsorption of hypoxanthine and other nu-
cleobases in the early part of the proximal tubule.
The di¡erences in Vmax values could also be due to
Table 4
Expression of the Na-dependent nucleobase transporter of
LLC-PK1 cells in Xenopus laevis oocytes
Assay conditions Na-dependent hypoxanthine uptake
(pmol/oocyte per h)
mRNA-injected Water-injected
Control 3.32 þ 0.14 2.15 þ 0.3
+100 WM Xanthine 0.82 þ 0.03 0.54 þ 0.05
Oocytes were injected with 50 nl of poly(A) RNA (1 Wg/Wl)
from LLC-PK1 cells or water and incubated for 3 days at
16‡C. Uptake of 1 WM [3H]hypoxanthine was determined at
22‡C for 20 min in the presence and absence of unlabelled xan-
thine in the presence of 100 mM NaCl or 100 mM choline
chloride. Na-dependent hypoxanthine uptake rates (£ux in the
presence of NaCl minus that in the presence of choline chlo-
ride) are presented (mean þ S.E.M. for 10 oocytes).
Table 3
Apparent Ki values for inhibition of Na-dependent hypoxan-
thine uptake in Xenopus laevis oocytes and LLC-PK1 renal epi-
thelial cells
Test compound Apparent Ki (WM)
Oocytes LLC-PK1
Thymine 5.5 þ 0.7 3.5 þ 0.2a
Xanthine 54.0 þ 6.1 NIa
Uracil 6.6 þ 1.1 2.9 þ 0.2a
5-Fluorouracil 5.9 þ 1.0 3.3 þ 0.4a
Oxypurinol 35.0 þ 4.2 NI
Adenine NI NI
2-Thiouracil NI ND
6-Azauracil NI ND
Uric acid NI NI
NI, no inhibition at 100 WM; ND, not determined. The initial
rate of Na-dependent hypoxanthine uptake (1 WM) was plot-
ted as a function of inhibitor concentration and IC50 values de-
termined as described in Table 2. Ki values are the means
þ S.E.M. of three separate experiments.
aData taken from [8].
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species di¡erences. Hypoxanthine in£ux via the Na/
hypoxanthine cotransporter in OK cells was strongly
inhibited by purine and pyrimidine nucleobases in-
cluding guanine, thymine, uracil and 5-£uorouracil
(Ki values 6 10 WM), and as is the case for Na-
dependent hypoxanthine transport in LLC-PK1 cells
adenine had no inhibitory e¡ect on hypoxanthine
uptake. Another similarity between the two cell types
was the discrimination dipyridamole and dilazep
showed in their inhibition of Na-dependent and
-independent hypoxanthine £ux. Both compounds
were relative potent inhibitors of Na-dependent hy-
poxanthine £ux. However, oxypurinol and xanthine,
nucleobases that had no e¡ect on Na-dependent
hypoxanthine in£ux in LLC-PK1 cells [8] (Table 3)
did inhibit Na-dependent hypoxanthine uptake by
OK cells (Ki values 6 60 WM). This result indicates
further heterogeneity in Na-dependent nucleobase
transporters to that previously reported occurring
both between species and tissues [8^13,26]. Charac-
terisation of hypoxanthine in£ux in Xenopus oocytes
also demonstrated that these cells possess a Na-de-
pendent hypoxanthine transport activity with proper-
ties similar to those in OK cells.
The structure^activity relationship of the permeant
site of the OK cell Na-dependent transporter was
examined by investigating the e¡ects of a range of
uracil analogues on hypoxanthine in£ux (Table 3).
The data clearly demonstrated that an oxo group
at both the 2- and 4-positions of uracil was required
for the interaction of uracil with the cotransporter.
Substitution of the N1 and N3 hydrogen with a hy-
drophobic group, e.g. methyl, also eliminated inter-
action of the uracil analogue with the carrier suggest-
ing that the region of the transporter adjacent to the
N1 and N3 position is either hydrophilic in nature or
sterically hindered.
OK cells were also shown to take up hypoxanthine
via a Na-independent transport system with over a
200-fold lower a⁄nity than the Na-dependent
transporter (Km 180 þ 59 vs 0.78 þ 0.29 WM). As is
the case for other Na-independent hypoxanthine
mammalian transporters [1,3,4], the carrier in OK
cells was preferentially inhibited by purine nucleo-
bases. The failure of NBMPR to inhibit Na-inde-
pendent hypoxanthine in£ux in OK cells suggests
that the NBMPR-sensitive nucleoside transporter in
these cells [20] does not mediate the uptake of hypo-
xanthine. Comparable studies with X. laevis oocytes
also demonstrated that oocytes possess a mediated
Na-independent route of hypoxanthine entry, but
in contrast to the system in OK cells was not inhib-
ited by adenine. This result suggests that hypoxan-
thine enters oocytes either via a novel system or via a
carrier that is not a speci¢c nucleobase transporter.
There is currently no knowledge of the molecular
properties of mammalian nucleobase transporters.
The Xenopus oocyte expression cloning strategy has
been successfully applied to the cloning of membrane
transport proteins especially where the level of trans-
port activity in the oocyte is low, e.g. nucleoside
uptake [15,16]. The ¢nding that X. laevis oocytes
possess a hypoxanthine £ux rate that is approxi-
mately 20-fold the rate of nucleoside in£ux
[15,16,27], and moreover the properties of Na-de-
pendent hypoxanthine £ux are similar to those in
OK cells, implied that it may be di⁄cult to detect
enhancement of hypoxanthine in£ux in oocytes fol-
lowing injection of OK poly(A) RNA. However,
the di¡erences in transport properties of Na-de-
pendent hypoxanthine transport between LLC-PK1
cells and oocytes suggested that pretreatment of oo-
cytes with 100 WM xanthine should reduce the endog-
enous £ux without an e¡ect on the £ux catalysed by
the LLC-PK1 hypoxanthine cotransporter. The re-
sults of Table 4 con¢rm that this was possible and
a 1.5-fold stimulation in Na-dependent hypoxan-
thine £ux was detectable. Unfortunately, in further
experiments, the expression of hypoxanthine £ux was
variable and current experiments are attempting to
reduce this variability by enriching the mRNA by
size fractionation before injecting into oocytes.
In conclusion, hypoxanthine transport in OK renal
epithelial cells derived from the early proximal tubule
and X. laevis oocytes was shown to occur by both a
Na-dependent nucleobase transport system that was
di¡erent from those previously characterised and by
a Na-independent nucleobase carrier. Functional
expression of renal Na-dependent nucleobase trans-
port activity was detected in oocytes following injec-
tion of mRNA, but expression was variable. Pro-
vided reproducible and higher levels of
hypoxanthine £ux can be achieved following micro-
injection, it should be possible to use the oocyte ex-
pression cloning strategy to isolate and clone Na-
dependent nucleobase transporters.
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